細胞株開發市場規模、佔有率、成長分析、按產品類型、按來源、按應用、按地區 - 產業預測，2024-2031 年

2022年，細胞株開發的全球市場規模為47億美元，從2023年的51.6億美元成長到2031年的109.4億美元，預計在預測期內（2024-2031年）將以複合年成長率成長。 9.84%。

由於該領域的快速發展以及對創新細胞技術和產品的投資增加，細胞株開發市場預計將顯著成長。全球對個人化醫療的需求不斷成長，加上細胞研究投資的增加，正在為該領域的提供者創造新的機會。此外，對治療各種疾病的生物相似藥和生技藥品的需求不斷成長，預計將進一步增強細胞株開發公司的未來性。未來幾年，專注於創造旨在改善醫療保健結果的新型藥物、療法和疫苗可能會刺激該領域的需求。此外，基因編輯技術的快速應用為專門從事細胞株開發的公司提供了良好的前景。然而，高開發成本、道德困境和可擴展性障礙等挑戰對整個預測期內及以後的市場成長構成了潛在障礙。總體而言，由於技術進步的融合、對先進醫療解決方案的需求不斷增加以及由於成長和機會而不斷追求醫療保健創新，細胞株開發市場面臨著多項挑戰。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 市場生態系統
• 案例研究分析
• 監管環境
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 競爭程度

細胞株開發市場：按類型

• 市場概況
• 初代細胞系
• 連續性細胞株
• 融合瘤
• 重組細胞株

細胞株開發市場：依產品分類

• 市場概況
• 按設備
  • 生物安全櫃
  • 細胞計數器和活力分析系統
  • 培養箱
  • 離心機
  • 反應器
  • 倉儲設備
  • 冰箱/冷凍庫
  • 冷凍系統
  • 自動化系統
  • 顯微鏡
  • 過濾系統
  • 其他設備
• 按介質和試劑
  • 血清
  • 牛（FBS）
  • 牛血清（ABS）
  • 其他動物血清
  • 中等的
  • 最低所需介質 (MEM)
  • 減少血清培養基
  • 無血清培養基（SFM）
  • 試劑
  • 補充品和生長因子
  • 緩衝液和化學品
  • 細胞分離試劑
  • 凍存試劑
  • 其他試劑

細胞株開發市場：依來源分類

• 市場概況
• 哺乳動物的
• 昆蟲
• 兩棲類

細胞株開發市場：依應用分類

• 市場概況
• 生物生產
  • 診斷
  • 疫苗生產
  • 重組蛋白療法
• 組織工程與再生醫學
• 毒性試驗
• 研究
• 藥物發現
  • 目標檢驗
  • 疾病模型
  • 藥物篩檢與開發

細胞株開發市場：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• American Type Culture Collection（ATCC）（US）
• Corning, Inc.（US）
• European Collection of Cell Cultures（ECACC）（UK）
• GE Healthcare（US）
• Lonza Group AG（Switzerland）
• Sartorius AG（Germany）
• JSR Life Sciences（US）
• MERCK KGaA（Germany）
• Thermo Fisher Scientific, Inc.（US）
• Wuxi Apptec（China）
• Celltrion, Inc.（South Korea）
• Bio-Techne Corporation（US）
• Charles River Laboratories International, Inc.（US）
• Eppendorf AG（Germany）
• Fujifilm Diosynth Biotechnologies（Japan）
• Promega Corporation（US）
• Danaher Corporation（US）
• Thermo Fisher Scientific（US）
• Perkin-Elmer（US）
• Cell Culture Technologies（US）
• Takara Bio Inc.（Japan）

Global Cell Line Development Market size was valued at USD 4.7 billion in 2022 and is poised to grow from USD 5.16 billion in 2023 to USD 10.94 billion by 2031, growing at a CAGR of 9.84% during the forecast period (2024-2031).

The cell line development market is poised for significant growth, driven by increasing investments in innovative cell technologies and products, alongside rapid advancements in the field. A rising global demand for personalized medicine, coupled with heightened investment in cell research, is paving the way for new opportunities for providers in this sector. Furthermore, the growing need for biosimilars and biologics to address an array of diseases is expected to further enhance prospects for cell line development firms. The focus on creating novel pharmaceuticals, therapeutics, and vaccines aimed at improving healthcare outcomes is likely to stimulate demand in this area in the coming years. Additionally, the burgeoning application of gene editing technologies presents lucrative prospects for companies specializing in cell line development. However, challenges such as high development costs, ethical dilemmas, and scalability hurdles pose potential barriers to market growth throughout the forecast period and beyond. Overall, while the cell line development market faces some challenges, the convergence of technological advancements, increasing demand for advanced medical solutions, and the ongoing pursuit of innovation in healthcare are set to create a robust environment for growth and opportunity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Line Development market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Line Development Market Segmental Analysis

Global Cell Line Development Market is segmented by Type, Product, Source, Application, and region. Based on Type, the market is segmented into Primary Cell Lines, Continuous Cell Lines, Hybridomas, and Recombinant Cell Lines. Based on Product, the market is segmented into Equipment, and Media & Reagents. Based on Source, the market is segmented into Mammalian, Insect, Amphibian. Based on Application, the market is segmented into Bioproduction, Tissue Engineering & Regenerative Medicine, Toxicity Testing, Research, Drug Discovery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Line Development Market

The global cell line development market is driven by the escalating investments in cell research, as healthcare researchers strive to harness the intricacies of cellular functions for innovative therapeutic solutions. This emphasis on cell line development is paramount, as it underpins critical advancements in drug discovery, regenerative medicine, and personalized therapies. As researchers unlock the full potential of various cell types, the demand for specialized cell lines surges, further propelling the market. Additionally, the expanding biopharmaceutical industry seeks to capitalize on cell lines for vaccine production and bioproduction, reinforcing the significant growth prospects within this dynamic market landscape.

Restraints in the Global Cell Line Development Market

The Global Cell Line Development market faces significant restraints primarily due to the complexity and intricacy involved in developing cell lines, resulting in high operational costs. The need for advanced technologies not only escalates financial investments but also requires specialized personnel and equipment, creating barriers for entry and competition. Additionally, ensuring consistency in cell line quality presents further challenges, leading to potential delays in research and production timelines. These factors collectively contribute to heightened development expenses and may deter companies from pursuing cell line development projects, thereby impacting overall market growth and demand in this sector.

Market Trends of the Global Cell Line Development Market

The Global Cell Line Development market is experiencing a notable trend towards 3D cell culture and organoid development, driven by the increasing demand for more accurate and physiologically relevant models in drug discovery and disease research. This shift is prompting cell line development companies to innovate and refine their offerings, focusing on specialized services and products that cater to the growing need for advanced 3D culture systems. By aligning their strategies with the proliferation of organoid technologies, these companies are poised to capture substantial market opportunities and enhance their competitive edge, underscoring a significant pivot towards advanced biotechnological solutions in cell line development.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Case study Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Cell Line Development Market by Type

• Market Overview
• Primary Cell Lines
• Continuous Cell Lines
• Hybridomas
• Recombinant Cell Lines

Cell Line Development Market by Product

• Market Overview
• By Equipment
  • Biosafety Cabinets
  • Cell Counters & Viability Analysis Systems
  • Incubators
  • Centrifuges
  • Bioreactors
  • Storage Equipment
  • Refrigerators & Freezers
  • Cryostorage Systems
  • Automation Systems
  • Microscopes
  • Filtration Systems
  • Other Equipment
• By Media & Reagents
  • Sera
  • Fetal Bovine Sera (FBS)
  • Adult Bovine Sera (ABS)
  • Other Animal Sera
  • Media
  • Minimum Essential Media (MEM)
  • Reduced Serum Media
  • Serum-Free Media (SFM)
  • Reagents
  • Supplements & Growth Factors
  • Buffers & Chemicals
  • Cell Dissociation Reagents
  • Cryopreservative Reagents
  • Other Reagents

Cell Line Development Market by Source

• Market Overview
• Mammalian
• Insect
• Amphibian

Cell Line Development Market by Application

• Market Overview
• Bioproduction
  • Diagnostics
  • Vaccine Production
  • Recombinant Protein Therapeutics
• Tissue Engineering & Regenerative Medicine
• Toxicity Testing
• Research
• Drug Discovery
  • Target Validation
  • Disease Modeling
  • Drug Screening and Development

Cell Line Development Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• American Type Culture Collection (ATCC) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• European Collection of Cell Cultures (ECACC) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JSR Life Sciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MERCK KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi Apptec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celltrion, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Diosynth Biotechnologies (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perkin-Elmer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Culture Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments